Macfarlanes has advised Nerano Pharma Limited on the provision of an interest-bearing secured convertible facility to Advanced Oncotherapy plc. Advanced Oncotherapy will use the funding to…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now